— Know what they know.
Not Investment Advice

XOMA

XOMA Royalty Corp.
1W: +7.4% 1M: +19.7% 3M: +24.2% YTD: +12.1% 1Y: +54.3% 3Y: +44.1% 5Y: -8.0%
$32.98
-0.10 (-0.30%)
After Hours: $33.87 (+0.89, +2.70%)
Weekly Expected Move ±5.4%
$27 $29 $30 $32 $33
NASDAQ · Healthcare · Biotechnology · $392.6M · Alpha Radar Buy · Power 72
Smart Money Score
Moderate 50
Insider+$2.5M
Congress
ETF Holdings
Key Statistics
Market Cap$392.6M
52W Range18.35-39.92
Volume91,630
Avg Volume367,509
Beta0.83
Dividend$2.16
Analyst Ratings
6 Buy 4 Hold 0 Sell
Consensus Buy
Company Info
CEOOwen Hughes Jr.
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date1986-06-06
Websitexoma.com
2200 Powell Street
EmeryVille, CA 94608
US
510 204 7200
About XOMA Royalty Corp.

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Recent Insider Trades

NameTypeSharesPriceDate
LIMBER JOSEPH M M-Exempt 3,026 $11.20 2026-03-27
LIMBER JOSEPH M M-Exempt 3,026 $11.20 2026-03-27
WYSZOMIERSKI JACK L M-Exempt 3,026 $11.20 2026-03-24
WYSZOMIERSKI JACK L M-Exempt 3,026 $11.20 2026-03-24
Hughes Owen A-Award 82,428 2026-03-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms